Truvvo Partners’s AngioDynamics ANGO Stock Holding History

Truvvo Partners’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-11,603	Closed	-$190K	–	128
2017 Q2	$190K	Hold	11,603	–	–	0.07%	124
2017 Q1	$201K	Sell	11,603 -22,030	-66%	-$368K	0.09%	112
2016 Q4	$567	Sell	33,633 -10,640	-24%	-$177K	0.2%	86
2016 Q3	$777K	Sell	44,273 -11,710	-21%	-$190K	0.35%	63
2016 Q2	$804K	Hold	55,983	–	–	0.41%	57
2016 Q1	$688K	Buy	55,983 +55	+0.1%	+$608	0.31%	64
2015 Q4	$679K	Buy	+55,928	New	+$689K	0.36%	59

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

Truvvo Partners's ANGO Position: Q3 2017 in Review

Truvvo Partners sold out of AngioDynamics (ANGO) in Q3 2017, closing a stake of 11,603 shares — an estimated $190K sold.

Truvvo Partners first reported a position in ANGO in Q4 2015 and held it in 7 quarters. The position peaked at $804K in Q2 2016. 168 funds tracked by Wall St. Rank hold ANGO as of Q3 2017.

Truvvo Partners reported no remaining AngioDynamics position as of Q3 2017 after selling out during the quarter.
Truvvo Partners sold 11,603 AngioDynamics shares in Q3 2017, an estimated $190K.
Truvvo Partners first reported a position in AngioDynamics in Q4 2015 and held it in 7 quarters.
Truvvo Partners's AngioDynamics position peaked at $804K in Q2 2016.
168 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2017.

Based on Truvvo Partners's 13F filing for Q3 2017, filed 14 Nov 2017.